ID   6F9
AC   CVCL_A6LM
DR   Wikidata; Q107113298
RX   Patent=WO1992017608A1;
RX   PubMed=2007622;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-1006.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=WO1992017608A1;
RA   Birchmeier W., Frixen U.H., Behrens J.;
RT   "Process for detecting the differentiation and invasiveness of
RT   carcinoma cells.";
RL   Patent number WO1992017608A1, 15-Oct-1992.
//
RX   PubMed=2007622; DOI=10.1083/jcb.113.1.173;
RA   Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A.,
RA   Lochner D., Birchmeier W.;
RT   "E-cadherin-mediated cell-cell adhesion prevents invasiveness of human
RT   carcinoma cells.";
RL   J. Cell Biol. 113:173-185(1991).
//